Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP568051.RAVcqqcYCMPIFJLO3fzrnRrnDcD-dCaaQ77c7R9cSDO6Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP568051.RAVcqqcYCMPIFJLO3fzrnRrnDcD-dCaaQ77c7R9cSDO6Y130_assertion type Assertion NP568051.RAVcqqcYCMPIFJLO3fzrnRrnDcD-dCaaQ77c7R9cSDO6Y130_head.
- NP568051.RAVcqqcYCMPIFJLO3fzrnRrnDcD-dCaaQ77c7R9cSDO6Y130_assertion description "[In conclusion, our results suggest that antiangiogenic gene therapy using tum-1 gene may be an efficient strategy for the treatment of HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP568051.RAVcqqcYCMPIFJLO3fzrnRrnDcD-dCaaQ77c7R9cSDO6Y130_provenance.
- NP568051.RAVcqqcYCMPIFJLO3fzrnRrnDcD-dCaaQ77c7R9cSDO6Y130_assertion evidence source_evidence_literature NP568051.RAVcqqcYCMPIFJLO3fzrnRrnDcD-dCaaQ77c7R9cSDO6Y130_provenance.
- NP568051.RAVcqqcYCMPIFJLO3fzrnRrnDcD-dCaaQ77c7R9cSDO6Y130_assertion SIO_000772 18575748 NP568051.RAVcqqcYCMPIFJLO3fzrnRrnDcD-dCaaQ77c7R9cSDO6Y130_provenance.
- NP568051.RAVcqqcYCMPIFJLO3fzrnRrnDcD-dCaaQ77c7R9cSDO6Y130_assertion wasDerivedFrom befree-20150227 NP568051.RAVcqqcYCMPIFJLO3fzrnRrnDcD-dCaaQ77c7R9cSDO6Y130_provenance.
- NP568051.RAVcqqcYCMPIFJLO3fzrnRrnDcD-dCaaQ77c7R9cSDO6Y130_assertion wasGeneratedBy ECO_0000203 NP568051.RAVcqqcYCMPIFJLO3fzrnRrnDcD-dCaaQ77c7R9cSDO6Y130_provenance.